Jazz Pharmaceuticals JAZZ Changes in unrecognized tax benefits
Changes in unrecognized tax benefits at other companies
Other financials
Where this comes from
Reported directly by Jazz Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:IncomeTaxReconciliationTaxContingencies.
The official record: Jazz Pharmaceuticals’s 10-K, filed February 24, 2026, on SEC EDGAR. View the filing →
Ask your AI about Jazz Pharmaceuticals's changes in unrecognized tax benefits.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Jazz Pharmaceuticals's changes in unrecognized tax benefits?
- Jazz Pharmaceuticals (JAZZ) reported changes in unrecognized tax benefits of -$1.61M in Q4 2025.
- How has Jazz Pharmaceuticals's changes in unrecognized tax benefits changed year-over-year?
- Jazz Pharmaceuticals's changes in unrecognized tax benefits decreased by 165.9% year-over-year, from $2.44M to -$1.61M.
- What is the long-term trend for Jazz Pharmaceuticals's changes in unrecognized tax benefits?
- Over 3 years (2021 to 2025), Jazz Pharmaceuticals's changes in unrecognized tax benefits has grown at a 0.0% compound annual growth rate (CAGR), from -$6.44M to -$6.44M.
- What does changes in unrecognized tax benefits mean?
- The net change in reserves held for potential tax disputes or uncertain tax positions.
- How do you interpret changes in unrecognized tax benefits?
- A decrease often signals the resolution of tax uncertainties or the expiration of statutes of limitations, which can be favorable.
- How does changes in unrecognized tax benefits compare across companies?
- Standard disclosure for all large corporations; reflects the company's risk appetite and tax audit environment.